XK
UTHR icon

Xact Kapitalforvaltning’s United Therapeutics UTHR Stock Holding History

Xact Kapitalforvaltning’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$645K Hold
6,800
– – 0.01% 647
2019
Q4 		$599K Hold
6,800
– – 0.01% 867
2019
Q3 		$542K Buy
6,800
+1,200
+21% +$96.6K 0.01% 868
2019
Q2 		$437K Sell
5,600
-7,204
-56% -$674K 0.01% 999
2019
Q1 		$1.5M Buy
12,804
+1,523
+14% +$177K 0.03% 449
2018
Q4 		$1.23M Hold
11,281
– – 0.03% 475
2018
Q3 		$1.44M Sell
11,281
-356
-3% -$44K 0.03% 485
2018
Q2 		$1.32M Sell
11,637
-700
-6% -$76.9K 0.03% 511
2018
Q1 		$1.39M Buy
12,337
+863
+8% +$110K 0.03% 492
2017
Q4 		$1.7M Buy
11,474
+424
+4% +$53.9K 0.04% 429
2017
Q3 		$1.29M Sell
11,050
-2,100
-16% -$268K 0.04% 460
2017
Q2 		$1.71M Buy
13,150
+152
+1% +$19K 0.05% 402
2017
Q1 		$1.76M Buy
12,998
+493
+4% +$74.7K 0.05% 395
2016
Q4 		$1.79M Sell
12,505
-1,790
-13% -$229K 0.06% 352
2016
Q3 		$1.69M Buy
+14,295
New +$1.72M 0.06% 354

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Xact Kapitalforvaltning's UTHR Position: Q1 2020 in Review

Xact Kapitalforvaltning held its United Therapeutics (UTHR) position steady in Q1 2020 at 6,800 shares worth $645K. The position accounts for 0.01% of the portfolio, ranked #647.

Xact Kapitalforvaltning first reported a position in UTHR in Q3 2016 and has held it in 15 quarters since. The position peaked at $1.79M in Q4 2016. 303 funds tracked by Wall St. Rank hold UTHR as of Q1 2020.

  • Xact Kapitalforvaltning held 6,800 shares of United Therapeutics worth $645K as of Q1 2020.
  • Xact Kapitalforvaltning left its United Therapeutics share count unchanged in Q1 2020.
  • United Therapeutics made up 0.01% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #647 holding.
  • Xact Kapitalforvaltning first reported a position in United Therapeutics in Q3 2016 and has held it in 15 quarters since.
  • Xact Kapitalforvaltning's United Therapeutics position peaked at $1.79M in Q4 2016.
  • 303 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.